Identification of potent RORβ modulators: Scaffold variation.

Area of Science:

• Medicinal Chemistry
• Molecular Pharmacology
• Drug Discovery

Background:

• Retinoic acid receptor-related Orphan Receptor beta (RORβ) is implicated in various physiological processes and disease pathophysiology.
• Investigating RORβ function requires selective chemical probes for in vitro and in vivo studies.
• Existing modulators often lack selectivity, potentially confounding biological interpretation.

Purpose of the Study:

• To design and synthesize novel probe molecules with high selectivity for RORβ over RORγ.
• To establish a series of potent RORβ modulators for further biological investigation.
• To explore structure-activity relationships (SAR) for RORβ-selective compounds.

Main Methods:

• Chemical modification of a known dual RORβ/RORγ inverse agonist.
• Structure-activity relationship (SAR) studies involving molecular truncation and core replacement.
• Synthesis and characterization of novel chemical entities targeting RORβ.

Main Results:

• Truncation of the Western portion of the lead molecule abolished RORγ activity.
• A series of potent RORβ modulators were identified.
• Successful exploration of alternative heterocyclic cores for the aminothiazole ring was achieved.

Conclusions:

• The developed compounds represent valuable RORβ-selective probes for biological research.
• These novel modulators offer improved selectivity, enabling more precise investigation of RORβ function.
• The SAR data provides a foundation for future optimization of RORβ-targeting therapeutics.